{{ company_name | default: "Cadence" }}
{{ chip_label | default: "Confidential · Seed Round" }}
{{ plan_label | default: "Business Plan · 2026" }}
{{ company_lockup | default: "Cadence" }}.
{{ tagline_lead | default: "AI scheduling & operations software for outpatient clinics" }} — {{ tagline_body | default: "recover the 30% of capacity that no-shows and broken booking workflows quietly burn." }}
Prepared by
{{ prepared_by | default: "Dr. Priya Nandakumar & Eli Park" }}
Round sought
{{ round_amount | default: "$1.5M" }} {{ round_stage | default: "Seed" }}
Date
{{ cover_date | default: "June 2026" }}
01

Executive Summary

{{ exec_tab | default: "The thesis" }}

{{ exec_lead | default: "Cadence is the AI scheduling and operations layer for outpatient clinics. We sit on top of the EHR and turn a clinic's calendar into a self-optimizing system — predicting no-shows, auto-filling gaps from a smart waitlist, and rebalancing provider load in real time." }}

{{ exec_body | default: "Outpatient clinics run on calendars they can't control. The average practice loses 14–20% of booked slots to no-shows and last-minute cancellations, and front-desk staff spend hours a day playing phone tag to backfill them. Cadence replaces that manual scramble with a model that predicts risk per appointment and fills the gap before it happens — lifting utilization without adding a single hour of staff time." }}

{% for m in exec_metrics %}
{{ m.value }}
{{ m.label }}
{% endfor %}
{{ exec_box1_label | default: "Why now" }}

{{ exec_box1_body | default: "EHR vendors finally opened FHIR write-access APIs in 2024, making real-time schedule automation possible for the first time without a custom integration per clinic. The plumbing exists; nobody has built the intelligence on top of it." }}

{{ exec_box2_label | default: "Why us" }}

{{ exec_box2_body | default: "Priya practiced as an outpatient physician for eight years and lived the no-show problem daily; Eli led ML infra at a digital-health unicorn. We pair clinical credibility with the engineering to ship against messy healthcare data." }}

{{ exec_callout_label | default: "The raise" }}

{{ exec_callout_headline | default: "$1.5M seed to go from 9 paying clinics to 80." }}

{{ exec_callout_body | default: "An 18-month runway to harden the EHR integrations, prove the no-show model across specialties, and build a repeatable sales motion into mid-size clinic groups — reaching default-alive on a Series A trajectory." }}

{{ exec_callout_ask | default: "$1.5M" }}
{{ company_legal | default: "Cadence, Inc." }}Confidential · 02
02

Product & Solution

{{ product_tab | default: "What we built" }}

{{ product_intro | default: "Cadence connects to the clinic's EHR in under a day, learns its booking patterns, and runs three loops continuously — predict, fill, and balance. Staff keep their existing calendar; Cadence works underneath it, surfacing actions instead of dashboards nobody reads." }}

{{ product_box1_label | default: "The wedge" }}

{{ product_box1_lead | default: "No-show prediction." }} {{ product_box1_body | default: "We start with the one number every clinic feels in revenue: the empty chair. Cadence scores every upcoming appointment for risk, then proactively fills high-risk slots from a ranked waitlist — a sharp, measurable ROI that gets us in the door before we expand across operations." }}

{{ product_box2_label | default: "How it works" }}
    {% for t in product_loops %}
  • {{ t.lead }} — {{ t.body }}
    • {% endfor %}
{{ pricing_label | default: "Pricing — per-provider SaaS, billed monthly" }}
{% for tier in pricing_tiers %}
{{ tier.name }}{{ tier.desc }}{{ tier.price }} {{ tier.unit }}
{% endfor %}
{{ product_callout_label | default: "Measured impact · pilot cohort" }}

{{ product_callout_headline | default: "+11 points of slot utilization in 90 days." }}

{{ product_callout_body | default: "Across our first nine clinics, Cadence lifted filled-slot rate from 81% to 92% and cut no-shows by a third — an average of $5,800 in recovered monthly revenue per provider, against a sub-$150 software cost." }}

{{ company_legal | default: "Cadence, Inc." }}Confidential · 03
03

Market

{{ market_tab | default: "The opportunity" }}

There are {{ market_lead_strong | default: "~280,000 outpatient clinic sites" }} {{ market_lead_body | default: "in the US employing roughly 1.1M providers. Scheduling inefficiency is a universal, recurring tax on every one of them — and it compounds with every empty chair." }}

{{ market_sizing_label | default: "Market sizing — top-down, US outpatient" }}
{% for b in tam_bars %}
{{ b.k }}
{{ b.lab }}
{{ b.value }}
{% endfor %}

{{ market_sizing_note | default: "TAM = 1.1M providers × $700/provider/yr blended ACV. SAM = clinics on FHIR-capable EHRs we can integrate today. SOM = realistic 3-yr capture at planned sales capacity." }}

{{ market_box1_label | default: "Ideal customer profile" }}
    {% for t in market_icp %}
  • {{ t.lead }} — {{ t.body }}
    • {% endfor %}
{{ market_box2_label | default: "Trends in our favor" }}

{{ market_box2_body | default: "Margin pressure is pushing clinics to recover revenue from existing capacity rather than add staff. FHIR write-access went GA across major EHRs in 2024–25. And patients now expect SMS-first, self-serve rescheduling — the exact surface Cadence automates." }}

{% for m in market_metrics %}
{{ m.value }}
{{ m.label }}
{% endfor %}
{{ company_legal | default: "Cadence, Inc." }}Confidential · 04
04

Competitive Landscape

{{ comp_tab | default: "The edge" }}

{{ comp_intro | default: "Reminders are a solved, commodity problem — and that's exactly the trap. Incumbents send texts; they don't decide who to overbook, which slot to fill, or how to protect a provider's day. Cadence is the only player closing the loop from prediction to action." }}

{{ comp_col1 | default: "Player" }}{{ comp_col2 | default: "Predicts" }}{{ comp_col3 | default: "Auto-fills" }}{{ comp_col4 | default: "Balances" }}
{% for c in competitors %}
{{ c.name }} {{ c.note }}{{ c.v2 }}{{ c.v3 }}{{ c.v4 }}
{% endfor %}
{{ comp_you_name | default: "Cadence" }}{{ comp_you_v2 | default: "Yes" }}{{ comp_you_v3 | default: "Yes" }}{{ comp_you_v4 | default: "Yes" }}
{{ comp_box1_label | default: "Our moat" }}
    {% for t in moat %}
  • {{ t.lead }} — {{ t.body }}
    • {% endfor %}
{{ comp_box2_label | default: "Honest risks" }}
    {% for t in risks %}
  • {{ t.lead }} — {{ t.body }}
    • {% endfor %}
{{ company_legal | default: "Cadence, Inc." }}Confidential · 05
05

Traction & Go-to-Market

{{ traction_tab | default: "The proof" }}

{{ traction_lead | default: "Nine paying clinics, $84K ARR run-rate, 22% MoM growth — all from founder-led sales and zero paid acquisition. The model works; we're raising to make selling it repeatable." }}

{{ traction_logos_label | default: "Current customers · representative" }}
{% for l in traction_logos %}
{{ l.nm }}
{{ l.sub }}
{% endfor %}
{{ traction_box1_label | default: "Unit economics · early" }}
{% for r in unit_economics_early %}
{{ r.line }}{% if r.sub %} {{ r.sub }}{% endif %}{{ r.amount }}
{% endfor %}
{{ unit_early_total_label | default: "LTV : CAC" }}{{ unit_early_total | default: "7.4×" }}
{{ traction_box2_label | default: "GTM motion" }}
    {% for t in gtm_motion %}
  • {{ t.lead }} — {{ t.body }}
    • {% endfor %}
{{ roadmap_label | default: "12-month product roadmap" }}
{% for s in roadmap %}
{{ s.n }}
{{ s.when }}

{{ s.body }}

{% endfor %}
{{ company_legal | default: "Cadence, Inc." }}Confidential · 06
06

Financial Plan

{{ fin_tab | default: "The numbers" }}

{{ fin_lead | default: "The $1.5M funds an 18-month runway to 80 paying clinics and a ~$1.2M ARR exit rate — the shape that supports a Series A. Plan holds with a 20% miss on growth." }}

{{ uof_label | default: "Use of funds · 18 months" }}
{{ uof_col1 | default: "Category" }}{{ uof_col2 | default: "Amount" }}
{% for r in use_of_funds %}
{{ r.item }}{% if r.sub %} {{ r.sub }}{% endif %}{{ r.amount }}
{% endfor %}
{{ uof_total_label | default: "Total raise" }}{{ uof_total | default: "$1.5M" }}

{{ uof_note | default: "~58% to product · ~28% to revenue · runway to Q4 2027." }}

{{ unit_scale_label | default: "Unit economics · at scale" }}
{{ unit_scale_col1 | default: "Metric" }}{{ unit_scale_col2 | default: "Target" }}
{% for r in unit_economics_scale %}
{{ r.line }}{% if r.sub %} {{ r.sub }}{% endif %}{{ r.amount }}
{% endfor %}
{{ unit_scale_total_label | default: "Rule of 40" }}{{ unit_scale_total | default: "62" }}

{{ unit_scale_note | default: "Software-margin economics; SMS pass-through is the only variable cost." }}

{{ arr_label | default: "Three-year ARR projection" }}
{% for b in arr_projection %}
{{ b.yr }}
{{ b.value }}
{% endfor %}

{{ arr_note | default: "Year-1 ARR is the seed exit rate (80 clinics). Years 2–3 assume the Series A funds the sales scale-up; NRR of 115%+ carries ~40% of net-new growth." }}

{{ company_legal | default: "Cadence, Inc." }}Confidential · 07
07

The Ask

{{ ask_tab | default: "Let's build" }}

{{ ask_lead | default: "Cadence has the wedge, the proof, and the team. The seed is what turns nine clinics into eighty — and a working product into a category-defining company." }}

{{ milestones_label | default: "Milestones to Series A" }}
{% for s in milestones %}
{{ s.n }}
{{ s.when }}

{{ s.body }}

{% endfor %}
{{ ask_callout_label | default: "Bottom line" }}

{{ ask_callout_headline | default: "$1.5M to own the operations layer of outpatient care." }}

{{ ask_callout_body | default: "The empty chair is a $150B problem every clinic feels and no incumbent solves end-to-end. We've proven clinics will pay for the fix and stay for it. This round buys the runway to make that motion repeatable — and to be the system clinics run their day on." }}

{{ ask_callout_ask | default: "$1.5M · Let's build." }}
Prepared by
{{ sign_name | default: "Dr. Priya Nandakumar & Eli Park · Co-founders" }}
{{ contact_line1 | default: "Cadence, Inc. · San Francisco, CA" }}
{{ contact_line2 | default: "[email protected] · cadence.health" }}
{{ company_legal | default: "Cadence, Inc." }} · {{ sign_short | default: "Nandakumar & Park" }}Confidential · 08